Read More 1 minute read Funding News News eGenesis Closes $191M Series D to Advance Human-Compatible Organ Transplants Key Highlights eGenesis secures $191M Series D financing led by Lux Capital and notable investors. Funding will advance lead kidney… byChris-Anne RoqueSeptember 5, 2024
Read More 1 minute read M&A News News Merck Acquires Caraway Therapeutics in a Landmark $610 Million Deal Key Highlights Merck to acquire Caraway Therapeutics, a biopharmaceutical company focusing on neurodegenerative and rare diseases, for a… byChris-Anne RoqueNovember 29, 2023